Company:  GUARDANT HEALTH, INC. (GH)
Form Type:  4
Filing Date:  1/13/2021 
CIK:  0001576280 
Address:  505 PENOBSCOT DR. 
City, State, Zip:  REDWOOD CITY, California 94063 
Telephone:  855-698-8887 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$159.94  
Change: 
0.65 (0.41%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$15.99B
Trade GH now with 

© 2021  
Description of Business
We are a leading precision oncology company focused on helping conquer cancer globally through use of our proprietary blood-based tests, vast data sets and advanced analytics. We believe that the key to conquering cancer is unprecedented access to its molecular information throughout all stages of the disease, which we intend to enable by a routine blood draw, or liquid biopsy. Our Guardant Health Oncology Platform is designed to leverage our capabilities in technology, clinical development, regulatory and reimbursement to drive commercial adoption of our tests, improve patient clinical outcomes, lower healthcare costs and accelerate drug development. In pursuit of our goal to manage cancer across all stages of the disease, we have launched our Guardant360 and GuardantOMNI tests for advanced stage cancer.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES